Ticker LaunchCanada to US · Cross-listing · LMNL
Liminal BioSciences Inc.
Liminal BioSciences Inc. (LMNL), a Ontario-based company, cross-listed on Nasdaq on Nov 12, 2019, registering its securities on Form 40FR12B. It is also listed in Canada on TSX: LMNL.
Liminal BioSciences Inc. is a clinical-stage biopharmaceutical company, existing under the Canada Business Corporations Act, that discovers and develops treatments for fibrosis-related diseases. Its focus includes respiratory, liver and kidney diseases, targeting pathways such as fatty acid receptors.
- Type
- Cross-listing
- US exchange
- Nasdaq
- Ticker
- LMNL
- Listed
- Nov 12, 2019
- Province
- Ontario
- Registration form
- 40FR12B
- Security
- Common shares
- Canadian listing
- TSX: LMNL
- Sector
- Biotech & pharma
More on this listing for subscribers
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration (40FR12B) Nov 12, 2019
- All filings on EDGAR CIK 1351172
Other Canadian companies listing in the US
- Newgioco Group, Inc.Nasdaq · Dec 23, 2019
- Metalla Royalty & Streaming Ltd.NYSE American · Dec 19, 2019
- Quantum Biopharma Ltd.Nasdaq · Dec 6, 2019
- Dirtt Environmental Solutions LtdNasdaq · Sep 20, 2019
- Equinox Gold Corp.NYSE American · Sep 10, 2019
- BELLUS Health Inc.Nasdaq · Sep 3, 2019